Pharmaceutical manufacturing

House Speaker Nancy Pelosi of Calif., gestures while speakings during a news conference on Capitol Hill in Washington, Thursday, Oct. 17, 2019. (AP Photo/Pablo Martinez Monsivais)
October 17, 2019 - 4:13 pm
WASHINGTON (AP) — House Speaker Nancy Pelosi is plowing ahead with her bill allowing Medicare to negotiate prescription drug prices despite a breakdown in relations with her chief bargaining partner on the issue — President Donald Trump. The nonpartisan Congressional Budget Office has estimated the...
Read More
FILE- This Nov. 14, 2018, file photo shows Lubriderm, a Johnson & Johnson product, on display at a market in Pittsburgh. Johnson & Johnson reports financial results Tuesday, Oct. 14, 2019. (AP Photo/Gene J. Puskar, File)
October 15, 2019 - 8:37 am
NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson's third-quarter profit jumped 23%, beating Wall Street forecasts, thanks to higher sales of its key medicines for cancer and immune disorders and an acquisition-related charge a year earlier. The world's biggest maker of health care products also...
Read More
FILE- This Nov. 14, 2018, file photo shows Lubriderm, a Johnson & Johnson product, on display at a market in Pittsburgh. Johnson & Johnson reports financial results Tuesday, Oct. 14, 2019. (AP Photo/Gene J. Puskar, File)
October 15, 2019 - 8:02 am
NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson's third-quarter profit jumped 23%, beating Wall Street forecasts, thanks to higher sales of its key medicines for cancer and immune disorders and an acquisition-related charge a year earlier. The world's biggest maker of health care products also...
Read More
FILE - In this Oct. 7, 2019, file photo specialists Mario Picone, left, and Anthony Rinaldi work on the floor of the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EDT on Monday, Oct. 14. (AP Photo/Richard Drew, File)
October 14, 2019 - 3:28 pm
Major U.S. stock indexes edged lower in afternoon trading Monday, a shaky start to the week for the market after the S&P 500 notched its first weekly gain in four weeks. Losses in consumer goods makers, utilities and industrial stocks outweighed gains in banks and elsewhere in the market...
Read More
Pharmacist Clint Hopkins displays the HIV prevention drugs Descovy, left and Truvada, right, at Pucci's Pharmacy in Sacramento, Calif., Monday, Oct. 7, 2019. Gov. Gavin Newsom signed a bill, SB159, by state Sen. Scott Wiener, D-San Francisco, Monday, authorizing pharmacists to sell the HIV preventative medications, to patients without a physician's prescription. (AP Photo/Rich Pedroncelli)
October 07, 2019 - 7:31 pm
SACRAMENTO, Calif. (AP) — Pharmacists in California will be able to dispense HIV prevention pills to patients without a doctor's prescription after Gov. Gavin Newsom signed legislation Monday that supporters say will greatly reduce the spread of infection. Advocates of Senate Bill 159 say...
Read More
Pharmacist Clint Hopkins displays the HIV prevention drugs Descovy, left and Truvada, right, at Pucci's Pharmacy in Sacramento, Calif., Monday, Oct. 7, 2019. Gov. Gavin Newsom signed a bill, SB159, by state Sen. Scott Wiener, D-San Francisco, Monday, authorizing pharmacists to sell the HIV preventative medications, to patients without a physician's prescription. (AP Photo/Rich Pedroncelli)
October 07, 2019 - 7:09 pm
SACRAMENTO, Calif. (AP) — Pharmacists in California will be able to dispense HIV prevention pills to patients without a doctor's prescription after Gov. Gavin Newsom signed legislation Monday that supporters say will greatly reduce the spread of infection. Advocates of Senate Bill 159 say...
Read More
FILE - In this Tuesday, Sept. 17, 2019 file photo, an employee of Eurotunnel and his dog check trucks on their way to Britain during a day of test in case of no deal Brexit, at the exit of the Channel tunnel in Calais, northern France. Britain’s government watchdog says there is still a “significant amount” of work to do to ensure Britain has an adequate medicines supply in case of a no-deal Brexit. In a report issued on Friday, Sept. 27, the National Audit Office said additional shipping capacity chartered by the U.K. for sending goods across the English channel might not be operational until the end of November - one month after the Oct. 31 deadline. (Denis Charlet, Pool via AP, file)
September 27, 2019 - 7:01 am
LONDON (AP) — Britain's government watchdog says there's still a "significant amount" of work to do to make sure the country has an adequate supply of licensed drugs in case of a no-deal Brexit. In a report issued Friday, Britain's National Audit Office said additional shipping capacity chartered...
Read More
FILE - In this Tuesday, Sept. 17, 2019 file photo, an employee of Eurotunnel and his dog check trucks on their way to Britain during a day of test in case of no deal Brexit, at the exit of the Channel tunnel in Calais, northern France. Britain’s government watchdog says there is still a “significant amount” of work to do to ensure Britain has an adequate medicines supply in case of a no-deal Brexit. In a report issued on Friday, Sept. 27, the National Audit Office said additional shipping capacity chartered by the U.K. for sending goods across the English channel might not be operational until the end of November - one month after the Oct. 31 deadline. (Denis Charlet, Pool via AP, file)
September 27, 2019 - 5:32 am
LONDON (AP) — Britain's government watchdog says there is still a "significant amount" of work to do to make sure the country has an adequate supply of licensed drugs in case of a no-deal Brexit. In a report issued Friday, Britain's National Audit Office said additional shipping capacity chartered...
Read More
CEO of the pharmaceutical giant Servier Olivier Laureau arrives at Paris courthouse Monday, Sept. 23, 2019. A massive trial with more than 4,000 plaintiffs is opening for French pharmaceutical giant Servier Laboratoires and France's medicines watchdog. (AP Photo/Michel Euler)
September 23, 2019 - 12:30 pm
PARIS (AP) — Victims of a diabetes drug suspected in hundreds of deaths pleaded for justice as a massive trial involving more than 4,000 plaintiffs opened Monday for French pharmaceutical giant Servier Laboratoires and France's medicines watchdog. The company and the oversight body stand accused of...
Read More
CEO of the pharmaceutical giant Servier Olivier Laureau arrives at Paris courthouse Monday, Sept. 23, 2019. A massive trial with more than 4,000 plaintiffs is opening for French pharmaceutical giant Servier Laboratoires and France's medicines watchdog. (AP Photo/Michel Euler)
September 23, 2019 - 11:14 am
PARIS (AP) — Victims of a diabetes drug suspected in hundreds of deaths pleaded for justice as a massive trial involving more than 4,000 plaintiffs opened Monday for French pharmaceutical giant Servier Laboratoires and France's medicines watchdog. The company and the oversight body stand accused of...
Read More

Pages